RESMED INC (RMD) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2017: $864.99M2018: $1.01B2019: $1.11B2020: $1.24B2021: $1.36B2022: $1.55B2023: $1.87B2024: $2.03B2025: $2.09B$2.09B
2017Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$2.09B+3.0%
2024$2.03B+8.7%
2023$1.87B+20.2%
2022$1.55B+14.4%
2021$1.36B+9.6%
2020$1.24B+11.4%
2019$1.11B+10.7%
2018$1.01B+16.2%
2017$864.99M